Clinical trial
Rapamycin+Estradiol- vs. Rapamycin-Eluting Stents to Reduce Restenosis…
NCT00402636 · Deutsches Herzzentrum Muenchen, Other · Completed
Key facts
| NCT number | NCT00402636 |
|---|---|
| Title | Rapamycin+Estradiol- vs. Rapamycin-Eluting Stents to Reduce Restenosis (ISAR-PEACE) |
| Official title | Prospective, Randomized Trial of Rapamycin Plus Estradiol-Eluting Stents Versus Rapamycin-Eluting Stents For The Reduction of Coronary Restenosis (ISAR-PEACE) |
| Lead sponsor | Deutsches Herzzentrum Muenchen, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Heart Disease |
| Intervention type | Device |
| Interventions | rapamycin plus 17beta estradiolvalerat-eluting stent, rapamycin-eluting stent |
| Enrollment | 502 |
| Start date | Mar 1, 2005 |
| Completion | Oct 1, 2006 |
| First posted | Nov 22, 2006 |
| Last update posted | Nov 28, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: